Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

“The Tome” to be broken down

Executive Summary

FDA's proposed rule on safety reporting requirements (dubbed "The Tome" for its large size) could be divided into "discrete pieces" to make it more palatable when it is finalized, Office of Pharmacoepidemiology & Statistical Science Director Paul Seligman tells Drug Information Association annual meeting. CDER Acting Director Steven Galson says the proposed rule, released in March 2003, is undergoing some "very, very serious surgical work" and the final reg will probably be something "quite different"...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS046031

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel